Published in Cancer Res on December 01, 1984
Sexually transmitted diseases, T cell subsets, and sexual practices in homosexual men attending an STD clinic. Genitourin Med (1985) 1.40
Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol (1987) 1.26
T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. J Virol (1987) 1.24
Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest (1986) 1.23
A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81
Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J Immunol (1968) 4.25
The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol (1968) 4.24
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis (1983) 3.86
Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med (1965) 3.54
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64
A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group. J Acquir Immune Defic Syndr (1990) 2.57
Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol (2001) 2.46
The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation. Clin Exp Immunol (1970) 2.40
Human cryptosporidiosis: spectrum of disease. Report of six cases and review of the literature. Arch Intern Med (1983) 2.10
Bacteremia caused by Campylobacter-like organisms in two male homosexuals. Ann Intern Med (1984) 2.07
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
Complications of cancer immunotherapy with levamisole. Lancet (1977) 1.76
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology (1991) 1.67
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst (1995) 1.67
Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis (1984) 1.67
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax (2009) 1.65
History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst (1990) 1.60
Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol (2006) 1.58
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med (1973) 1.57
Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med (1984) 1.57
Cancer immunotherapy. Can Med Assoc J (1979) 1.54
Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol (1986) 1.50
Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med (1988) 1.48
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Familial patterns of prostate cancer: a case-control analysis. J Urol (1991) 1.45
Usefulness of flow volume loops in emergency center and ICU settings. Chest (1997) 1.43
Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv (1983) 1.43
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood (2001) 1.43
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy. Ann Oncol (2011) 1.42
Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplant (1999) 1.41
Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma. Cancer Res (1977) 1.40
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer. J Natl Cancer Inst (1977) 1.40
Cells capable of colony formation in the peripheral blood of man. Science (1971) 1.40
Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system. Int J Cancer (2011) 1.38
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med (1971) 1.38
Testicular cancer associated with employment in agriculture and oil and natural gas extraction. Lancet (1984) 1.35
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG. Science (1971) 1.33
Antigen dose in the human immune response. Dose-relationships in the human immune response to Keyhole limpet hemocyanin. J Lab Clin Med (1971) 1.32
Chronic immune stimulation by sperm alloantigens. Support for the hypothesis that spermatozoa induce immune dysregulation in homosexual males. JAMA (1984) 1.31
Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol (1998) 1.31
Pulmonary complications of acute leukemia. Cancer (1966) 1.30
Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer (1971) 1.29
Immunological characterization of homosexual males. Cancer Res (1983) 1.29
Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol (1971) 1.29
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol (1987) 1.26
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. Ann Oncol (2006) 1.25
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Acquired immune deficiency syndrome: postmortem findings. Am J Clin Pathol (1984) 1.24
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. Cancer Res (1984) 1.23
Lymphocyte activation: a rapid test to predict allograft rejection. Nature (1970) 1.22
Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment. Biochem Pharmacol (1976) 1.21
Food group contributions to nutrient intake in whites, blacks, and Mexican Americans in Texas. J Am Diet Assoc (1989) 1.21
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations. Ann Oncol (2008) 1.21
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan. Transplantation (1972) 1.18
Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology (2001) 1.17
Multiple primary neoplasms in blacks compared to whites. 3. Initial cancers of the female breast and uterus. J Natl Cancer Inst (1974) 1.17
Hepatotoxic effects of methotrexate. Cancer (1966) 1.17
Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Res (1990) 1.16
Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Antimicrob Agents Chemother (1984) 1.15
AIDS exacerbates psoriasis. N Engl J Med (1985) 1.15
Microbiology experience in collection of human tissue. Am J Clin Pathol (1966) 1.15
The human secondary immune response to Keyhole limpet haemocyanin. Clin Exp Immunol (1972) 1.15
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes. Ann Oncol (2013) 1.14
Antibody responses to bacteriophage phi X-174 in human subjects exposed to the antarctic winter-over model of spaceflight. J Allergy Clin Immunol (2001) 1.14
The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med (1988) 1.14
Sensitivity of multiple myeloma to imexon in the human tumor cloning assay. J Natl Cancer Inst (1994) 1.13
Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J Virol (1990) 1.13
American Cancer Society guidelines on diet, nutrition, and cancer. The Work Study Group on Diet, Nutrition, and Cancer. CA Cancer J Clin (1991) 1.13
Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon. Surg Gynecol Obstet (1974) 1.13
Lymphadenopathy in homosexual men. Morbid anatomy with clinical and immunologic correlations. Am J Clin Pathol (1983) 1.13
In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. J Immunol (1991) 1.12
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin Cancer Res (2000) 1.11
Special report on Laetrile: the NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis. N Engl J Med (1978) 1.11
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res (1985) 1.10
Inhibition of in vitro lymphocyte transformation during chemotherapy in man. Cancer Res (1967) 1.09
Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res (1973) 1.09
Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol (1997) 1.08
Major head injuries in fights and brawls. Med Sci Law (1968) 1.08
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol (1985) 1.07
Epidemiologic comparison of cancer of the testis and Hodgkin's disease among young males. Cancer (1984) 1.07
Treatment of a presumed case of sympathetic ophthalmia with methotrexate. Arch Ophthalmol (1966) 1.07
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Ann Oncol (2009) 1.07
The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver. Lancet (1981) 1.06
Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 1.06
The inhibition of lymphocyte blastogenesis by L-asparaginase. Blood (1970) 1.06
Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer Chemother Pharmacol (1999) 1.05
Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol (1989) 1.05
Primitive leiomyosarcoma of the breast: case report and review of the literature. Breast (2004) 1.04